Equities

Allurion Technologies Inc

ALUR:NYQ

Allurion Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.69
  • Today's Change-0.08 / -4.52%
  • Shares traded45.78k
  • 1 Year change-83.86%
  • Beta--
Data delayed at least 15 minutes, as of May 20 2024 15:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.

  • Revenue in USD (TTM)53.47m
  • Net income in USD-82.30m
  • Incorporated2023
  • Employees249.00
  • Location
    Allurion Technologies Inc11 Huron Dr Ste 200NATICK 01760United StatesUSA
  • Phone+1 (508) 647-4000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.allurion.com/en
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Quantum Computing Inc358.05k-29.73m72.41m39.00--0.8379--202.23-0.4182-0.41820.0050.9460.0043--1.139,180.77-35.39-79.71-37.91-87.9845.36---8,303.50-26,197.810.673-16.510.033--163.95--22.96--213.36--
Arqit Quantum Inc640.00k-73.91m73.31m147.00--1.07--114.55-0.5621-0.53540.0050.40750.0057--0.11754,353.74-66.09---85.43-------11,548.13-----275.070.1119---91.13---238.38------
Dynastar Holdings Inc80.65k-43.72k73.51m1.00--306.71--911.52-0.0002-0.00010.00030.00011.53----80,650.00-83.09---152.63-------54.21------0.00---5.84--62.26------
Vicarious Surgical Inc0.00-61.15m74.34m131.00--0.8847-----0.3927-0.39270.000.47730.00----0.00-54.03---56.98--------------0.00-------1,478.15------
Katapult Holdings Inc221.59m-36.67m75.19m90.00----0.8370.3393-8.94-8.9454.21-6.871.92--88.642,462,089.00-31.76---52.93--18.82---16.55-12.38---1.061.48--5.77--9.40------
XBP Europe Holdings Inc0.00-22.20m76.32m-----------2.69-2.690.00-3.390.00-------112.71---238.25-------------0.158--------240.15------
Upland Software Inc291.53m-141.37m76.71m1.06k--3.87--0.2631-4.75-4.759.334.970.3389--7.37274,771.00-15.81-8.53-18.73-9.9568.4967.37-46.64-28.16---1.520.7738---6.1314.72-163.63--5.47--
Xiao-I Corp (ADR)59.17m-26.46m78.53m281.00------1.33-0.373-0.3730.84-0.06750.932347.231.61210,552.50-42.56---231.36--66.63---45.64--0.6588-9.761.33--22.79---348.62------
Forian Inc20.48m1.73m80.45m36.0066.883.1444.503.930.03980.33510.62750.84670.3896--4.82568,925.803.30-26.223.85-29.6573.2668.868.46-80.48----0.4872---26.8716.45106.67---13.46--
EUDA Health Holdings Ltd3.71m-8.44m81.85m106.00------22.08-0.3685-0.43840.1707-0.30450.2752--3.5534,966.61-62.62------22.72---227.57-----1.49-----1.54--66.17------
SilverSun Technologies Inc55.82m-1.21m81.86m195.00--10.76--1.47-0.2306-0.230610.581.432.66--17.18286,280.80-5.76-3.07-12.23-5.7939.2539.85-2.17-1.26--26.210.2022--21.195.86-279.17---30.83--
Cyber App cCorp313.20k-11.75m83.32m11.00------266.04-0.16-0.160.0042-0.12320.0364----28,472.73-136.51-----------3,750.77-----1.931.98--------------
Allurion Technologies Inc53.47m-82.30m84.82m249.00------1.59-1.91-1.911.24-1.48------214,722.90--------77.61---150.76--0.8964-------16.73---102.46------
Retrieve Medical Holdings Inc0.00-217.85k85.52m1.00---------0.556-0.5560.00-1.540.00-------147.43-90.16---------------8.84---------116.81------
WiMi Hologram Cloud Inc - ADR81.04m-58.31m94.29m107.00--0.9045--1.16-0.6608-0.66080.9291.060.5109342.5126.57757,359.40-44.55-22.26-55.40-26.1129.6727.65-87.19-36.033.67--0.061---14.2121.04-17.74--329.51--
Data as of May 20 2024. Currency figures normalised to Allurion Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

13.51%Per cent of shares held by top holders
HolderShares% Held
RTW Investments LPas of 16 Apr 20243.46m7.23%
Olayan Europe Ltd.as of 31 Mar 20241.24m2.60%
BlackRock Fund Advisorsas of 31 Mar 2024471.39k0.99%
The Vanguard Group, Inc.as of 31 Mar 2024453.97k0.95%
Geode Capital Management LLCas of 31 Mar 2024344.91k0.72%
Lumyna Investments Ltd.as of 30 Sep 2022299.03k0.63%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202469.62k0.15%
SSgA Funds Management, Inc.as of 31 Mar 202443.91k0.09%
Sage Rock Capital Management LPas of 31 Mar 202442.00k0.09%
Accredited Investors, Inc.as of 31 Mar 202437.50k0.08%
More ▼
Data from 30 Sep 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.